S&P 500
(-1.46%) 5 123.41 points
Dow Jones
(-1.24%) 37 983 points
Nasdaq
(-1.62%) 16 175 points
Oil
(0.51%) $85.45
Gas
(0.51%) $1.773
Gold
(-0.53%) $2 360.20
Silver
(-0.99%) $27.97
Platinum
(0.18%) $989.80
USD/EUR
(0.79%) $0.939
USD/NOK
(0.59%) $10.89
USD/GBP
(0.83%) $0.803
USD/RUB
(0.01%) $93.28

Realtime updates for Yuhan Corporation [000105.KS]

Exchange: KSC Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated12 Apr 2024 @ 02:30

1.29% KRW 62 600

Live Chart Being Loaded With Signals

Commentary (12 Apr 2024 @ 02:30):

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally...

Stats
Today's Volume 829.00
Average Volume 2 485.00
Market Cap 5 288.93B
EPS KRW0 ( 2023-09-30 )
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW153.79 (0.25%)

Volume Correlation

Long: -0.01 (neutral)
Short: -0.19 (neutral)
Signal:(53.581) Neutral

Yuhan Corporation Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Yuhan Corporation Correlation - Currency/Commodity

The country flag 0.28
( neutral )
The country flag 0.55
( weak )
The country flag -0.21
( neutral )
The country flag 0.22
( neutral )
The country flag -0.65
( moderate negative )
The country flag -0.50
( neutral )

Yuhan Corporation Financials

Annual 2023
Revenue: KRW1 858.98B
Gross Profit: KRW595.83B (32.05 %)
EPS: KRW1 815.36
Q4 2023
Revenue: KRW437.15B
Gross Profit: KRW437.15B (100.00 %)
EPS: KRW1 235.13
Q3 2023
Revenue: KRW483.06B
Gross Profit: KRW144.49B (29.91 %)
EPS: KRW278.82
Q2 2023
Revenue: KRW495.72B
Gross Profit: KRW152.82B (30.83 %)
EPS: KRW121.53

Financial Reports:

No articles found.

Yuhan Corporation

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury; ETC products in the areas of cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems; anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. It also offers OTC products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. In addition, the company engages in dental business and offers implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and household pets. Further, it provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators